Cargando…
A phase I study of pemetrexed (LY231514) supplemented with folate and vitamin B(12) in Japanese patients with solid tumours
The purpose of this study was to determine the maximum tolerated dose (MTD) and recommended dose (RD) of pemetrexed with folate and vitamin B12 supplementation (FA/VB(12)) in Japanese patients with solid tumours and to investigate the safety, efficacy, and pharmacokinetics of pemetrexed. Eligible pa...
Autores principales: | Nakagawa, K, Kudoh, S, Matsui, K, Negoro, S, Yamamoto, N, Latz, J E, Adachi, S, Fukuoka, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360511/ https://www.ncbi.nlm.nih.gov/pubmed/16940981 http://dx.doi.org/10.1038/sj.bjc.6603321 |
Ejemplares similares
-
Dipyridamole potentiates the in vitro activity of MTA (LY231514) by inhibition of thymidine transport
por: Smith, P G, et al.
Publicado: (2000) -
Preclinical cellular pharmacology of LY231514 (MTA): a comparison with methotrexate, LY309887 and raltitrexed for their effects on intracellular folate and nucleoside triphosphate pools in CCRF-CEM cells.
por: Chen, V. J., et al.
Publicado: (1998) -
Reduced folate and serum vitamin metabolites in patients with rectal carcinoma: an open-label feasibility study of pemetrexed with folic acid and vitamin B(12) supplementation
por: Stoffregen, Clemens C., et al.
Publicado: (2016) -
Dose-escalation study of weekly irinotecan and daily carboplatin with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer
por: Yamada, M, et al.
Publicado: (2002) -
Phase I and pharmacologic study of BNP7787, a novel chemoprotector in patients with advanced non-small cell lung cancer
por: Masuda, Noriyuki, et al.
Publicado: (2010)